Ardiden Ltd (ASX:ADV) Quarterly Activities Report


(MENAFN- ABN Newswire)

Ardiden Ltd (ASX:ADV) provides the Company's Quarterly Activities Report.

HIGHLIGHTS

SEYMOUR LAKE LITHIUM PROJECT (100% ADV)

- Ardiden completed the Resource expansion and exploration drilling program at the North Aubry Lithium Deposit during the December quarter. Highlights from the program include the following:

o ASD006: 9.01m* @ 1.70% Li2O from 150.64m;

o ASD007: 8.58m* @ 1.31% Li2O from 162.42m;

o ASD009: 27.46m* @ 1.90% Li2O from 208.76m;

o ASD010: 23.98m* @ 1.54% Li2O from 212.10m;

-- Including 0.55*m @ 5.67% Li2O from 214.75m; and

o ASD011: 37.61m* @ 1.95% Li2O from 224.92m.

o ASD012: 17.91m* @ 0.85% Li2O from 126.95m;

o ASD013: 12.28m* @ 1.03% Li2O from 126.20m;

o ASD017: 15.06m* @ 1.11% Li2O from 112.94m;

-- Including 1.00m* @ 4.26% Li2O from 121.50m; and

o ASD019: 5.02m* @ 0.67% Li2O from 168.55m.

*Note: stated lengths of intersections are down-hole lengths and the true thickness of the intersected pegmatites is not yet precisely defined.

- Ardiden is now focused on completing an updated Mineral Resource estimate, compliant with the 2012 JORC Code, for the Seymour Lake Lithium Project.

To view the full report, please visit:
http://abnnewswire.net/lnk/5K3I471L

Ardiden Limited ( ASX:ADV ) is an emerging international diversified exploration and development company possessing a mature multi-element asset portfolio, with a near term development pipeline, focused quality projects located in the established mining jurisdiction of Ontario, Canada.

Investors:Neil HackettArdiden LtdTel: +61-8-6245-2050Media:Michael Weir / Cameron GilenkoCitadel-MagnusTel: +61-8-6160-4900

MENAFN3001201901110000ID1098043510


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.